Cepheid has announced US FDA clearance of the Xpert Hemorrhagic Fever Panel, a multiplex PCR test that detects Ebola, Marburg, Lassa and Crimean-Congo hemorrhagic fever viruses from a single sample.
The company says results are available in about 61 minutes on GeneXpert Dx systems, in a closed cartridge that includes a viral inactivation step. It received World Health Organization Emergency Use Listing for the test in September 2026. The test is not available in all countries.
Source: Cepheid (press release)
Date: 3 November 2026
Original: https://cepheid.mediaroom.com/2026-11-03-Cepheid-Receives-FDA-Clearance-for-Xpert-R-Hemorrhagic-Fever-Panel-Test
